While semaglutide itself does not directly cause anemia, its effects on appetite, nutrient absorption, or gastrointestinal function can contribute to it indirectly

Side Effects & Safety Typical first-cycle side effects: Weeks 1-2: mild water retention, vivid dreams, light head/warmth after injection Weeks 3-4: occasional joint stiffness, improved sleep quality, slight appetite increase overnight Weeks 5-8: adaptation phase most side effects fade, body composition changes visible Clinical discontinuation signals (trial-reported): Clinical participants in tesamorelin studies were discontinued upon experiencing: Persistent headaches with visual changes (intracranial pressure marker in trial monitoring protocols) Sustained fasting glucose elevation of ~15 mg/dL above baseline Unusual peripheral swelling persisting beyond weeks 1-2 Carpal tunnel symptoms unresponsive to dose titration in community-reported protocols Tesamorelin has been studied at 2mg/day for 6+ months without notable safety signals at therapeutic doses
Indian Pharma Network (IPN), New Delhi
Key takeaways Sulfur burps and diarrhea are potential side effects of Ozempic, often linked to changes in digestion
Muscle Spasms: Sometimes, the muscles in the lower back can spasm or tighten up in response to pain or injury